John C Canzano, MD
Ophthalmology · Stockton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
- Since medical school
- 32 years
- Emory University School of Medicine, 1994
Offices
5 locations · Zeiter Eye Medical Group Inc · 11 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Canzano’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A55787 · Current
Licensed to practise in California · since 1996 · expires 2028-02-29 · Emory University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Zeiter Eye Surgical Center, Inc.Ambulatory Surgery Center · Stockton, CA26% owner since 2006 · accredited by AAAHCAccreditation Renewed5 inspections, 5 with deficiencies · last 2025-12-10: Requirements Met
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Ophthalmology - Ophthalmology
Original Medicare doctor bills
$1,876,865
Medicare paid this office $1,876,865 for 1,806 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, faricimab-svoa, 0.1 mg | 76 | $778,811 | None |
| Injection, aflibercept, 1 mg | 42 | $252,898 | None |
| Removal of cataract with insertion of prosthetic lens | 333 | $220,969 | $403 |
| Return visit (30+ min) | 1,022 | $108,247 | $91 |
| Removal of recurring cataract in lens capsule using a laser | 193 | $70,507 | $249 |
See all 23 services
| Injection, faricimab-svoa, 0.1 mg | 76 | $778,811 | None |
| Injection, aflibercept, 1 mg | 42 | $252,898 | None |
| Removal of cataract with insertion of prosthetic lens | 333 | $220,969 | $403 |
| Return visit (30+ min) | 1,022 | $108,247 | $91 |
| Removal of recurring cataract in lens capsule using a laser | 193 | $70,507 | $249 |
| Injection of drug into eye | 137 | $63,423 | $105 |
| Injection, ranibizumab, 0.1 mg | 24 | $58,304 | None |
| New patient visit (45+ min) | 435 | $47,627 | $109 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 262 | $43,593 | $131 |
| Imaging of retina | 1,059 | $35,332 | $29 |
| Complex removal of cataract with insertion of prosthetic lens | 52 | $34,984 | $547 |
| Short return visit (20+ min) | 426 | $33,856 | $65 |
| Measurement of corneal curvature and depth of eye | 439 | $20,186 | $30 |
| Photography of the retina | 435 | $12,641 | $28 |
| Exam of visual field with extended testing | 243 | $11,543 | $47 |
| Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 19 | $9,847 | None |
| Removal of cataract with insertion of prosthetic lens and laser treatment to decrease fluid production in eye | 11 | $9,525 | $476 |
| Imaging of optic nerve | 264 | $7,604 | $26 |
| Destruction of leaking blood vessels of retina using laser | 12 | $4,344 | $241 |
| Closure of tear duct opening using plug | 18 | $3,180 | $177 |
| Ultrasound scan of cornea to determine thickness | 82 | $612 | $7 |
| Injection of drug or substance into membrane covering eyeball | 12 | $391 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $10 | None |
Procedures Medicare counted
| Cataract surgery | 884 | More than 98% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of drug into eye | 472 | 558 | 592 | 559 | 628 | 602 |
| Removal of cataract with insertion of prosthetic lens | 576 | 398 | 489 | 615 | 667 | 548 |
| Removal of recurring cataract in lens capsule using a laser | 222 | 176 | 193 | 251 | 276 | 283 |
| Complex removal of cataract with insertion of prosthetic lens | 38 | 55 | 44 | 40 | 48 | 64 |
| Destruction of leaking blood vessels of retina using laser | 24 | 33 | 32 | 17 | 16 | 18 |
| Removal of cataract with insertion of prosthetic lens and laser treatment to decrease fluid production in eye | – | 19 | 26 | 24 | 29 | 20 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,806 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 15% · Women 61% · Also on Medicaid 16% · Health risk score 1.14. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 39% · Chronic kidney disease 29% · Coronary heart disease 27% · Atrial fibrillation 16% · Heart failure 14% · Cancer 14% · Depression 13% · COPD 12% · Stroke 7% · Dementia 5%.
The office billed $4,601,120, Medicare allowed $2,418,725 and paid $1,876,865; for 56,455 services of 47 kinds; $1,127,129 of it was for drugs given in the office and $749,736 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,806 | 56,455 | 76 | 1.14 | $4,601,120 | $1,876,865 |
| 2023 | 1,706 | 37,995 | 76 | 1.14 | $4,721,661 | $1,962,861 |
| 2022 | 1,633 | 10,038 | 76 | 1.10 | $3,647,565 | $1,528,863 |
| 2021 | 1,547 | 8,958 | 76 | 1.21 | $3,604,193 | $1,709,504 |
| 2020 | 1,366 | 7,904 | 76 | 1.24 | $3,106,460 | $1,503,199 |
| 2019 | 1,566 | 7,964 | 76 | 1.25 | $3,105,475 | $1,493,077 |
| 2018 | 1,449 | 7,470 | 75 | 1.25 | $3,127,995 | $1,512,839 |
| 2017 | 1,401 | 7,304 | 76 | 1.35 | $3,377,665 | $1,672,675 |
| 2016 | 1,274 | 7,861 | 75 | 1.41 | $3,105,270 | $1,612,906 |
| 2015 | 1,261 | 7,550 | 75 | 1.40 | $2,856,395 | $1,479,865 |
| 2014 | 1,208 | 6,102 | 75 | 1.37 | $1,715,310 | $740,633 |
| 2013 | 1,168 | 5,105 | 75 | 1.33 | $1,438,220 | $569,519 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Injection, faricimab-svoa, 0.1 mg | 76 | $881,972 | None |
| Removal of cataract with insertion of prosthetic lens | 385 | $265,067 | $397 |
| Injection, aflibercept, 1 mg | 36 | $218,763 | None |
| Injection, ranibizumab, 0.1 mg | 41 | $113,083 | None |
| Return visit (30+ min) | 856 | $90,746 | $92 |
| Removal of recurring cataract in lens capsule using a laser | 202 | $71,256 | $258 |
| Injection of drug into eye | 128 | $68,905 | $110 |
| New patient visit (45+ min) | 468 | $53,457 | $114 |
| Imaging of retina | 1,009 | $33,963 | $30 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 229 | $30,288 | $113 |
| Short return visit (20+ min) | 378 | $29,214 | $63 |
| Complex removal of cataract with insertion of prosthetic lens | 38 | $27,601 | $575 |
| Measurement of corneal curvature and depth of eye | 514 | $24,748 | $32 |
| Removal of cataract with insertion of prosthetic lens and laser treatment to decrease fluid production in eye | 16 | $15,725 | $542 |
| Photography of the retina | 295 | $8,704 | $29 |
| Exam of visual field with extended testing | 178 | $8,541 | $48 |
| Imaging of optic nerve | 233 | $7,030 | $27 |
| Destruction of leaking blood vessels of retina using laser | 11 | $3,814 | $238 |
| Ultrasound scan of cornea to determine thickness | 61 | $496 | $8 |
2022: 22 services
| Injection, ranibizumab, 0.1 mg | 81 | $432,029 | None |
| Injection, aflibercept, 1 mg | 42 | $298,166 | None |
| Removal of cataract with insertion of prosthetic lens | 356 | $246,913 | $401 |
| Return visit (30+ min) | 910 | $106,552 | $92 |
| Removal of recurring cataract in lens capsule using a laser | 184 | $63,769 | $254 |
| Injection of drug into eye | 127 | $60,529 | $108 |
| New patient visit (45+ min) | 431 | $51,639 | $120 |
| Imaging of retina | 1,031 | $36,718 | $31 |
| Injection, faricimab-svoa, 0.1 mg | 12 | $32,229 | None |
| Exam of retinal blood vessels using a special camera after injection of a dye | 239 | $31,539 | $103 |
| Measurement of corneal curvature and depth of eye | 494 | $25,204 | $33 |
| Short return visit (20+ min) | 335 | $24,478 | $66 |
| Complex removal of cataract with insertion of prosthetic lens | 30 | $21,397 | $535 |
| Removal of cataract with insertion of prosthetic lens and laser treatment to decrease fluid production in eye | 14 | $13,993 | $583 |
| Photography of the retina | 261 | $7,652 | $28 |
| Exam of visual field with extended testing | 154 | $7,145 | $46 |
| Imaging of optic nerve | 210 | $6,412 | $27 |
| Destruction of growth of retina using a laser | 13 | $5,648 | $377 |
| Destruction of leaking blood vessels of retina using laser | 15 | $3,702 | $218 |
| Long return visit (40+ min) | 14 | $2,175 | $121 |
| Ultrasound scan of cornea to determine thickness | 57 | $484 | $8 |
| Exam of the internal drainage system of eye | 18 | $429 | $24 |
2021: 20 services
| Injection, ranibizumab, 0.1 mg | 77 | $505,333 | None |
| Injection, aflibercept, 1 mg | 48 | $493,272 | None |
| Removal of cataract with insertion of prosthetic lens | 287 | $204,258 | $418 |
| Return visit (30+ min) | 1,061 | $133,713 | $96 |
| Injection of drug into eye | 128 | $66,932 | $113 |
| Removal of recurring cataract in lens capsule using a laser | 144 | $49,302 | $255 |
| New patient visit (45+ min) | 394 | $48,930 | $124 |
| Imaging of retina | 1,053 | $38,543 | $31 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 256 | $33,979 | $100 |
| Complex removal of cataract with insertion of prosthetic lens | 35 | $25,628 | $582 |
| Measurement of corneal curvature and depth of eye | 398 | $23,153 | $37 |
| Removal of cataract with insertion of prosthetic lens and laser treatment to decrease fluid production in eye | 16 | $14,492 | $557 |
| Destruction of growth of retina using a laser | 19 | $10,729 | $413 |
| Short return visit (20+ min) | 122 | $9,922 | $72 |
| Exam of visual field with extended testing | 172 | $9,020 | $51 |
| Destruction of leaking blood vessels of retina using laser | 24 | $7,960 | $249 |
| Imaging of optic nerve | 200 | $6,633 | $28 |
| Photography of the retina | 151 | $5,033 | $32 |
| Long return visit (40+ min) | 11 | $1,573 | $143 |
| Ultrasound scan of cornea to determine thickness | 62 | $523 | $8 |
2020: 23 services
| Injection, ranibizumab, 0.1 mg | 53 | $471,728 | None |
| Injection, aflibercept, 1 mg | 46 | $452,529 | None |
| Removal of cataract with insertion of prosthetic lens | 241 | $167,549 | $421 |
| Injection of drug into eye | 107 | $55,462 | $99 |
| Return visit (30+ min) | 610 | $49,978 | $80 |
| Removal of recurring cataract in lens capsule using a laser | 136 | $45,188 | $257 |
| Short return visit (20+ min) | 504 | $41,898 | $58 |
| Imaging of retina | 972 | $36,155 | $32 |
| Complex removal of cataract with insertion of prosthetic lens | 42 | $32,528 | $591 |
| New patient visit (45+ min) | 210 | $26,601 | $127 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 224 | $25,253 | $88 |
| Measurement of corneal curvature and depth of eye | 328 | $20,606 | $41 |
| Removal of cataract with insertion of prosthetic lens and laser treatment to decrease fluid production in eye | 12 | $10,999 | $579 |
| New patient visit (30+ min) | 106 | $8,797 | $83 |
| Destruction of leaking blood vessels of retina using laser | 24 | $8,387 | $254 |
| Exam of visual field with extended testing | 166 | $8,143 | $48 |
| Destruction of growth of retina using a laser | 13 | $7,788 | $410 |
| Imaging of optic nerve | 195 | $6,017 | $27 |
| Internal insertion of eye fluid drainage device | 11 | $4,997 | $263 |
| Injection, bevacizumab, 10 mg | 12 | $2,927 | None |
| Photography of the retina | 65 | $2,271 | $35 |
| Ultrasound scan of cornea to determine thickness | 62 | $561 | $9 |
| Exam of the internal drainage system of eye | 22 | $523 | $24 |
2019: 22 services
| Injection, aflibercept, 1 mg | 42 | $482,366 | None |
| Injection, ranibizumab, 0.1 mg | 50 | $308,903 | None |
| Removal of cataract with insertion of prosthetic lens | 344 | $279,897 | $486 |
| Removal of recurring cataract in lens capsule using a laser | 159 | $58,972 | $266 |
| Return visit (30+ min) | 703 | $58,063 | $80 |
| Short return visit (20+ min) | 604 | $47,093 | $57 |
| Injection of drug into eye | 106 | $46,422 | $98 |
| Imaging of retina | 1,030 | $39,927 | $32 |
| New patient visit (45+ min) | 285 | $34,926 | $123 |
| Measurement of corneal curvature and depth of eye | 417 | $28,448 | $44 |
| Complex removal of cataract with insertion of prosthetic lens | 31 | $23,535 | $619 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 236 | $22,753 | $77 |
| Exam of visual field with extended testing | 217 | $10,998 | $49 |
| Destruction of growth of retina using a laser | 18 | $9,664 | $420 |
| New patient visit (30+ min) | 104 | $8,779 | $84 |
| Imaging of optic nerve | 216 | $6,772 | $28 |
| Destruction of leaking blood vessels of retina using laser | 15 | $6,193 | $258 |
| Injection, bevacizumab, 10 mg | 18 | $3,139 | None |
| Photography of the retina | 56 | $2,235 | $40 |
| Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | 11 | $2,195 | $200 |
| Ultrasound scan of cornea to determine thickness | 50 | $503 | $10 |
| Photography of content of eyes | 25 | $374 | $15 |
2018: 19 services
| Injection, aflibercept, 1 mg | 53 | $511,186 | None |
| Injection, ranibizumab, 0.1 mg | 41 | $336,364 | None |
| Removal of cataract with insertion of prosthetic lens | 342 | $272,922 | $472 |
| Return visit (30+ min) | 752 | $63,841 | $78 |
| Injection of drug into eye | 119 | $54,655 | $96 |
| Removal of recurring cataract in lens capsule using a laser | 145 | $54,384 | $261 |
| New patient visit (45+ min) | 322 | $39,459 | $123 |
| Imaging of retina | 804 | $31,370 | $32 |
| Measurement of corneal curvature and depth of eye | 420 | $29,895 | $48 |
| Short return visit (20+ min) | 393 | $28,068 | $56 |
| Complex removal of cataract with insertion of prosthetic lens | 24 | $20,514 | $622 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 204 | $17,186 | $71 |
| Exam of visual field with extended testing | 192 | $9,862 | $50 |
| Destruction of leaking blood vessels of retina using laser | 22 | $8,384 | $254 |
| Injection, bevacizumab, 10 mg | 24 | $8,063 | None |
| Imaging of optic nerve | 176 | $5,153 | $27 |
| New patient visit (30+ min) | 65 | $5,057 | $78 |
| Photography of content of eyes | 23 | $334 | $14 |
| Ultrasound scan of cornea to determine thickness | 30 | $294 | $10 |
2017: 22 services
| Injection, aflibercept, 1 mg | 80 | $776,701 | None |
| Injection, ranibizumab, 0.1 mg | 46 | $303,580 | None |
| Removal of cataract with insertion of prosthetic lens | 304 | $228,648 | $460 |
| Return visit (30+ min) | 865 | $73,249 | $71 |
| Injection of drug into eye | 143 | $56,685 | $96 |
| Removal of recurring cataract in lens capsule using a laser | 122 | $43,568 | $241 |
| New patient visit (45+ min) | 262 | $29,917 | $114 |
| Measurement of corneal curvature and depth of eye | 372 | $26,340 | $47 |
| Imaging of retina | 597 | $21,465 | $30 |
| Complex removal of cataract with insertion of prosthetic lens | 27 | $20,327 | $581 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 249 | $19,149 | $66 |
| Short return visit (20+ min) | 229 | $13,527 | $53 |
| Destruction of growth of retina using a laser | 20 | $12,362 | $386 |
| Exam of visual field with extended testing | 159 | $7,145 | $44 |
| Destruction of leaking blood vessels of retina using laser | 22 | $7,139 | $216 |
| Injection, bevacizumab, 10 mg | 22 | $5,191 | None |
| Photography of the retina | 96 | $4,625 | $47 |
| Imaging of optic nerve | 156 | $4,114 | $25 |
| New patient visit (30+ min) | 63 | $4,013 | $64 |
| Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | 19 | $3,510 | $185 |
| Established patient complete exam of visual system | 12 | $1,087 | $91 |
| Ultrasound scan of cornea to determine thickness | 60 | $625 | $10 |
2016: 22 services
| Injection, aflibercept, 1 mg | 75 | $720,523 | None |
| Injection, ranibizumab, 0.1 mg | 49 | $292,032 | None |
| Removal of cataract with insertion of prosthetic lens | 225 | $178,594 | $489 |
| Return visit (30+ min) | 715 | $66,843 | $77 |
| Injection of drug into eye | 154 | $62,565 | $94 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 273 | $56,738 | $86 |
| Removal of recurring cataract in lens capsule using a laser | 110 | $39,458 | $255 |
| Complex removal of cataract with insertion of prosthetic lens | 32 | $25,123 | $613 |
| Short return visit (20+ min) | 386 | $24,953 | $54 |
| Measurement of corneal curvature and depth of eye | 302 | $24,486 | $33 |
| Imaging of retina | 577 | $23,871 | $33 |
| New patient visit (45+ min) | 173 | $21,622 | $125 |
| Destruction of leaking blood vessels of retina using laser | 37 | $12,449 | $249 |
| Injection, bevacizumab, 10 mg | 48 | $12,122 | None |
| New patient visit (30+ min) | 149 | $9,799 | $66 |
| Exam of visual field with extended testing | 181 | $9,098 | $49 |
| Imaging of optic nerve | 177 | $5,810 | $32 |
| Exam of blood vessels between the white part of eye and retina using a special camera after injection of a dye | 13 | $5,020 | $201 |
| Photography of the retina | 75 | $4,491 | $56 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 13 | $3,921 | $196 |
| Ultrasound scan of cornea to determine thickness | 105 | $1,200 | $11 |
| Exam of the internal drainage system of eye | 17 | $376 | $22 |
2015: 22 services
| Injection, ranibizumab, 0.1 mg | 58 | $461,947 | None |
| Injection, aflibercept, 1 mg | 50 | $408,012 | None |
| Removal of cataract with insertion of prosthetic lens | 231 | $187,232 | $484 |
| Return visit (30+ min) | 642 | $63,803 | $83 |
| Injection of drug into eye | 140 | $57,675 | $95 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 252 | $48,765 | $86 |
| Complex removal of cataract with insertion of prosthetic lens | 41 | $37,521 | $615 |
| Removal of recurring cataract in lens capsule using a laser | 81 | $27,926 | $259 |
| Destruction of leaking blood vessels of retina using laser | 26 | $27,113 | $775 |
| New patient visit (45+ min) | 224 | $25,821 | $115 |
| Measurement of corneal curvature and depth of eye | 310 | $25,284 | $34 |
| Short return visit (20+ min) | 374 | $23,309 | $52 |
| Imaging of retina | 518 | $23,146 | $34 |
| Injection, bevacizumab, 10 mg | 60 | $11,756 | None |
| New patient visit (30+ min) | 115 | $9,445 | $82 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 22 | $7,318 | $188 |
| Exam of blood vessels between the white part of eye and retina using a special camera after injection of a dye | 16 | $6,401 | $200 |
| Exam of visual field with extended testing | 124 | $6,388 | $52 |
| Imaging of optic nerve | 118 | $4,030 | $34 |
| Established patient complete exam of visual system | 27 | $2,324 | $86 |
| Ultrasound scan of cornea to determine thickness | 98 | $1,130 | $12 |
| Exam of the internal drainage system of eye | 25 | $515 | $21 |
2014: 21 services
| Removal of cataract with insertion of prosthetic lens | 225 | $181,276 | $501 |
| Injection, ranibizumab, 0.1 mg | 24 | $123,713 | None |
| Injection of drug into eye | 132 | $54,124 | $95 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 260 | $47,372 | $85 |
| Short return visit (20+ min) | 570 | $40,792 | $52 |
| Complex removal of cataract with insertion of prosthetic lens | 50 | $40,179 | $618 |
| Injection, bevacizumab, 10 mg | 125 | $33,923 | None |
| Destruction of leaking blood vessels of retina using laser | 27 | $31,977 | $799 |
| Removal of recurring cataract in lens capsule using a laser | 88 | $31,604 | $259 |
| Return visit (30+ min) | 271 | $22,420 | $82 |
| Measurement of corneal curvature and depth of eye | 282 | $22,141 | $33 |
| Imaging of retina | 451 | $20,377 | $34 |
| New patient visit (45+ min) | 163 | $18,224 | $112 |
| New patient visit (30+ min) | 214 | $17,073 | $80 |
| Exam of visual field with extended testing | 112 | $6,003 | $52 |
| Exam of blood vessels between the white part of eye and retina using a special camera after injection of a dye | 15 | $5,862 | $195 |
| Imaging of optic nerve | 100 | $3,488 | $34 |
| Microfluid analysis of tears | 49 | $2,165 | $22 |
| Established patient complete exam of visual system | 16 | $1,480 | $92 |
| Ultrasound scan of cornea to determine thickness | 79 | $922 | $8 |
| Exam of the internal drainage system of eye | 13 | $296 | $23 |
2013: 21 services
| Removal of cataract with insertion of prosthetic lens | 226 | $178,103 | $502 |
| Removal of recurring cataract in lens capsule using a laser | 136 | $50,216 | $262 |
| Injection of drug into eye | 133 | $43,420 | $89 |
| Short return visit (20+ min) | 576 | $41,897 | $53 |
| New patient visit (45+ min) | 323 | $39,066 | $121 |
| Injection, bevacizumab, 10 mg | 132 | $31,327 | None |
| Exam of retinal blood vessels using a special camera after injection of a dye | 167 | $28,807 | $86 |
| Complex removal of cataract with insertion of prosthetic lens | 36 | $26,740 | $608 |
| Destruction of leaking blood vessels of retina using laser | 23 | $25,307 | $767 |
| Measurement of corneal curvature and depth of eye | 277 | $22,199 | $34 |
| Imaging of retina | 383 | $17,532 | $35 |
| Return visit (30+ min) | 186 | $13,387 | $70 |
| Exam of blood vessels between the white part of eye and retina using a special camera after injection of a dye | 37 | $12,664 | $176 |
| Established patient complete exam of visual system | 106 | $8,903 | $83 |
| Destruction of growth of retina using a laser | 12 | $6,637 | $415 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 16 | $5,755 | $198 |
| Exam of visual field with extended testing | 96 | $4,810 | $50 |
| Imaging of optic nerve | 88 | $2,797 | $32 |
| New patient visit (30+ min) | 24 | $1,495 | $62 |
| Ultrasound scan of cornea to determine thickness | 42 | $466 | $7 |
| Exam of the internal drainage system of eye | 14 | $316 | $23 |
Medicaid work
$41,810 in 2024
Medicaid paid $41,810 for 519 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Intravitreal injection of a pharmacologic agent (separate procedure) | 86 | $20,407 |
| Return visit (30+ min) | 198 | $9,753 |
| New patient visit (45+ min) | 84 | $7,187 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 137 | $4,008 |
| Short return visit (20+ min) | 14 | $454 |
| 2024 | 519 | 5 | 23 | $41,810 |
| 2023 | 609 | 5 | 24 | $77,540 |
| 2022 | 514 | 5 | 22 | $91,681 |
| 2021 | 587 | 6 | 25 | $113,723 |
| 2020 | 208 | 3 | 18 | $37,640 |
| 2019 | 261 | 4 | 19 | $22,886 |
| 2018 | 218 | 4 | 19 | $45,348 |
See the largest Medicaid services in earlier years
2023
| Intravitreal injection of a pharmacologic agent (separate procedure) | 162 | $43,692 |
| Ranibizumab injection | 13 | $17,037 |
| Return visit (30+ min) | 176 | $8,005 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 218 | $6,110 |
| New patient visit (45+ min) | 40 | $2,697 |
2022
| Ranibizumab injection | 30 | $39,398 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 149 | $37,642 |
| Return visit (30+ min) | 188 | $8,374 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 135 | $5,085 |
| FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI | 12 | $1,182 |
2021
| Intravitreal injection of a pharmacologic agent (separate procedure) | 220 | $49,075 |
| Ranibizumab injection | 28 | $30,736 |
| Aflibercept injection | 12 | $21,137 |
| Return visit (30+ min) | 192 | $8,973 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 100 | $3,802 |
| TOBACCO NON-USER | 35 | $0 |
2020
| Intravitreal injection of a pharmacologic agent (separate procedure) | 154 | $35,274 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 42 | $1,798 |
| Short return visit (20+ min) | 12 | $569 |
2019
| Intravitreal injection of a pharmacologic agent (separate procedure) | 74 | $14,556 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 94 | $3,891 |
| Short return visit (20+ min) | 67 | $2,579 |
| FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI | 26 | $1,860 |
2018
| Intravitreal injection of a pharmacologic agent (separate procedure) | 165 | $41,958 |
| Injection, bevacizumab, 10 mg | 12 | $1,350 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 28 | $1,192 |
| FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI | 13 | $848 |
Drugs they prescribed that Part D paid
$443,642
Pharmacies billed $443,642 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,052) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
1,194 generic and 1,858 brand-name prescriptions · $443,642 in drug cost · 12 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 91 | $88,684 | $975 |
| Lumigan | 89 | $54,993 | $618 |
| Prednisolone Acetate | 983 | $48,215 | $49 |
| Cyclosporine | 42 | $25,896 | $617 |
| Combigan | 48 | $20,036 | $417 |
See all 21 drugs
| Restasis | 91 | $88,684 | $975 |
| Lumigan | 89 | $54,993 | $618 |
| Prednisolone Acetate | 983 | $48,215 | $49 |
| Cyclosporine | 42 | $25,896 | $617 |
| Combigan | 48 | $20,036 | $417 |
| Xiidra | 15 | $16,444 | $1,096 |
| Latanoprost | 770 | $11,561 | $15 |
| Brimonidine Tartrate-Timolol | 41 | $9,237 | $225 |
| Travoprost | 21 | $5,890 | $280 |
| Brimonidine | 126 | $5,580 | $44 |
| Loteprednol Etabonate | 15 | $4,199 | $280 |
| Tobramycin-Dexamethasone | 62 | $3,896 | $63 |
| Tobradex St | 12 | $2,798 | $233 |
| Diclofenac | 321 | $2,772 | $9 |
| Timolol Maleate | 69 | $1,009 | $15 |
| Ketorolac Tromethamine | 63 | $910 | $14 |
| Dorzolamide-Timolol | 46 | $861 | $19 |
| Dorzolamide | 43 | $778 | $18 |
| Moxifloxacin | 32 | $641 | $20 |
| Erythromycin | 30 | $399 | $13 |
| Neomycin-Polymyxin-Dexameth | 30 | $339 | $11 |
Year by year
| 2024 | 3,052 | 1,182 | 0% (0) | 61% | $443,642 |
| 2023 | 2,816 | 944 | 0% (0) | 62% | $395,875 |
| 2022 | 2,487 | 808 | 0% (0) | 60% | $406,722 |
| 2021 | 2,423 | 719 | 0% (0) | 64% | $355,445 |
| 2020 | 1,893 | 575 | 0% (0) | 65% | $314,975 |
| 2019 | 1,666 | 509 | None | 59% | $272,496 |
| 2018 | 1,546 | 466 | None | 59% | $226,794 |
| 2017 | 1,276 | 384 | 0% (0) | 54% | $167,010 |
| 2016 | 1,911 | 508 | None | 52% | $183,660 |
| 2015 | 2,279 | 572 | None | 53% | $203,238 |
| 2014 | 2,422 | 658 | None | 52% | $184,658 |
| 2013 | 2,751 | 724 | None | 54% | $197,344 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Restasis | 128 | $135,247 | $1,057 |
| Lumigan | 101 | $61,109 | $605 |
| Prednisolone Acetate | 737 | $37,839 | $51 |
| Combigan | 67 | $23,641 | $353 |
| Latanoprost | 817 | $19,612 | $24 |
| Cyclosporine | 24 | $19,531 | $814 |
| Xiidra | 14 | $17,989 | $1,285 |
| Brimonidine Tartrate-Timolol | 40 | $11,611 | $290 |
| Tobramycin-Dexamethasone | 109 | $9,019 | $83 |
| Alphagan P | 12 | $7,819 | $652 |
| Prolensa | 21 | $7,560 | $360 |
| Brimonidine | 98 | $6,613 | $67 |
| Loteprednol Etabonate | 36 | $6,433 | $179 |
| Travoprost | 18 | $4,977 | $276 |
| Diclofenac | 259 | $3,250 | $13 |
| Timolol Maleate | 66 | $1,432 | $22 |
| Dorzolamide-Timolol | 48 | $1,119 | $23 |
| Fluorometholone | 11 | $949 | $86 |
| Moxifloxacin | 26 | $941 | $36 |
| Dorzolamide | 42 | $797 | $19 |
| Neomycin-Polymyxin-Dexameth | 41 | $509 | $12 |
| Acyclovir | 11 | $102 | $9 |
2022: 21 drugs
| Restasis | 134 | $163,159 | $1,218 |
| Lumigan | 109 | $58,334 | $535 |
| Prednisolone Acetate | 539 | $31,900 | $59 |
| Combigan | 80 | $28,634 | $358 |
| Latanoprost | 835 | $16,617 | $20 |
| Tobramycin-Dexamethasone | 99 | $10,727 | $108 |
| Brimonidine Tartrate-Timolol | 27 | $9,460 | $350 |
| Brimonidine | 85 | $7,726 | $91 |
| Alphagan P | 16 | $7,603 | $475 |
| Rocklatan | 14 | $6,061 | $433 |
| Prolensa | 17 | $5,556 | $327 |
| Travoprost | 19 | $5,299 | $279 |
| Loteprednol Etabonate | 16 | $4,548 | $284 |
| Diclofenac | 140 | $2,020 | $14 |
| Timolol Maleate | 45 | $1,804 | $40 |
| Moxifloxacin | 32 | $1,489 | $47 |
| Dorzolamide-Timolol | 38 | $890 | $23 |
| Dorzolamide | 39 | $727 | $19 |
| Neomycin-Polymyxin-Dexameth | 44 | $573 | $13 |
| Erythromycin | 17 | $301 | $18 |
| Acyclovir | 15 | $165 | $11 |
2021: 23 drugs
| Restasis | 124 | $146,271 | $1,180 |
| Lumigan | 112 | $44,042 | $393 |
| Combigan | 114 | $37,583 | $330 |
| Prednisolone Acetate | 501 | $28,495 | $57 |
| Latanoprost | 819 | $15,977 | $20 |
| Xiidra | 17 | $13,758 | $809 |
| Tobramycin-Dexamethasone | 148 | $13,733 | $93 |
| Prolensa | 24 | $7,464 | $311 |
| Travoprost | 14 | $5,340 | $381 |
| Alphagan P | 16 | $5,026 | $314 |
| Moxifloxacin | 59 | $2,829 | $48 |
| Loteprednol Etabonate | 14 | $2,701 | $193 |
| Brimonidine | 92 | $2,651 | $29 |
| Durezol | 12 | $2,567 | $214 |
| Olopatadine | 40 | $1,909 | $48 |
| Dorzolamide-Timolol | 36 | $1,291 | $36 |
| Timolol Maleate | 46 | $1,142 | $25 |
| Atropine Sulfate | 14 | $964 | $69 |
| Diclofenac | 66 | $922 | $14 |
| Dorzolamide | 20 | $505 | $25 |
| Erythromycin | 22 | $274 | $12 |
| Neomycin-Polymyxin-Dexameth | 17 | $257 | $15 |
| Acyclovir | 12 | $224 | $19 |
2020: 20 drugs
| Restasis | 131 | $156,830 | $1,197 |
| Lumigan | 112 | $39,356 | $351 |
| Combigan | 62 | $24,238 | $391 |
| Prednisolone Acetate | 398 | $19,183 | $48 |
| Latanoprost | 749 | $13,159 | $18 |
| Xiidra | 20 | $10,830 | $541 |
| Pazeo | 19 | $6,661 | $351 |
| Loteprednol Etabonate | 26 | $5,376 | $207 |
| Brimonidine | 50 | $4,128 | $83 |
| Alphagan P | 19 | $3,787 | $199 |
| Durezol | 17 | $3,518 | $207 |
| Tobradex | 11 | $2,586 | $235 |
| Tobramycin-Dexamethasone | 25 | $2,563 | $103 |
| Olopatadine | 40 | $1,789 | $45 |
| Moxifloxacin | 21 | $1,097 | $52 |
| Timolol Maleate | 39 | $624 | $16 |
| Dorzolamide-Timolol | 13 | $491 | $38 |
| Diclofenac | 26 | $459 | $18 |
| Dorzolamide | 14 | $415 | $30 |
| Neomycin-Polymyxin-Dexameth | 11 | $185 | $17 |
2019: 23 drugs
| Restasis | 127 | $122,782 | $967 |
| Lumigan | 96 | $35,080 | $365 |
| Combigan | 45 | $14,899 | $331 |
| Travatan Z | 33 | $12,734 | $386 |
| Prednisolone Acetate | 246 | $12,487 | $51 |
| Latanoprost | 604 | $9,895 | $16 |
| Restasis Multidose | 16 | $9,322 | $583 |
| Durezol | 45 | $8,748 | $194 |
| Prolensa | 18 | $5,903 | $328 |
| Lotemax | 19 | $5,690 | $299 |
| Alphagan P | 33 | $5,453 | $165 |
| Pazeo | 14 | $3,238 | $231 |
| Tobramycin-Dexamethasone | 31 | $3,018 | $97 |
| Olopatadine | 35 | $2,419 | $69 |
| Dorzolamide-Timolol | 14 | $1,237 | $88 |
| Moxifloxacin | 21 | $992 | $47 |
| Brimonidine | 33 | $992 | $30 |
| Timolol Maleate | 44 | $758 | $17 |
| Diclofenac | 38 | $486 | $13 |
| Ketorolac Tromethamine | 15 | $287 | $19 |
| Erythromycin | 25 | $283 | $11 |
| Ciprofloxacin | 15 | $152 | $10 |
| Acyclovir | 11 | $152 | $14 |
2018: 19 drugs
| Restasis | 110 | $104,411 | $949 |
| Lumigan | 98 | $32,024 | $327 |
| Prednisolone Acetate | 272 | $14,628 | $54 |
| Travatan Z | 30 | $12,858 | $429 |
| Combigan | 47 | $10,697 | $228 |
| Restasis Multidose | 17 | $8,861 | $521 |
| Latanoprost | 562 | $8,467 | $15 |
| Alphagan P | 29 | $4,852 | $167 |
| Azopt | 14 | $4,017 | $287 |
| Ilevro | 12 | $3,053 | $254 |
| Tobramycin-Dexamethasone | 23 | $2,718 | $118 |
| Brimonidine | 50 | $1,977 | $40 |
| Olopatadine | 21 | $1,550 | $74 |
| Ketorolac Tromethamine | 46 | $1,336 | $29 |
| Timolol Maleate | 47 | $558 | $12 |
| Moxifloxacin | 13 | $479 | $37 |
| Diclofenac | 24 | $378 | $16 |
| Erythromycin | 35 | $369 | $11 |
| Ciprofloxacin | 13 | $116 | $9 |
2017: 16 drugs
| Restasis | 75 | $63,781 | $850 |
| Lumigan | 141 | $38,391 | $272 |
| Prednisolone Acetate | 155 | $10,516 | $68 |
| Combigan | 45 | $9,270 | $206 |
| Latanoprost | 484 | $6,199 | $13 |
| Pataday | 18 | $4,320 | $240 |
| Lotemax | 12 | $3,933 | $328 |
| Alphagan P | 19 | $3,427 | $180 |
| Olopatadine | 21 | $2,170 | $103 |
| Tobramycin-Dexamethasone | 16 | $1,917 | $120 |
| Brimonidine | 43 | $1,834 | $43 |
| Dorzolamide-Timolol | 25 | $1,090 | $44 |
| Diclofenac | 75 | $1,038 | $14 |
| Timolol Maleate | 25 | $332 | $13 |
| Ketorolac Tromethamine | 11 | $331 | $30 |
| Ciprofloxacin | 23 | $327 | $14 |
2016: 18 drugs
| Restasis | 85 | $58,548 | $689 |
| Lumigan | 143 | $32,840 | $230 |
| Prednisolone Acetate | 282 | $23,413 | $83 |
| Pataday | 64 | $10,858 | $170 |
| Combigan | 52 | $9,054 | $174 |
| Lotemax | 34 | $8,387 | $247 |
| Travatan Z | 37 | $7,565 | $204 |
| Latanoprost | 430 | $5,233 | $12 |
| Diclofenac | 276 | $3,683 | $13 |
| Alphagan P | 22 | $3,527 | $160 |
| Durezol | 21 | $3,235 | $154 |
| Ciprofloxacin | 239 | $2,191 | $9 |
| Tobramycin-Dexamethasone | 19 | $1,875 | $99 |
| Fluorometholone | 11 | $750 | $68 |
| Brimonidine | 40 | $623 | $16 |
| Dorzolamide-Timolol | 14 | $446 | $32 |
| Timolol Maleate | 15 | $162 | $11 |
| Erythromycin | 16 | $137 | $9 |
2015: 19 drugs
| Restasis | 124 | $67,000 | $540 |
| Prednisolone Acetate | 421 | $39,539 | $94 |
| Lumigan | 114 | $22,969 | $201 |
| Pataday | 83 | $14,164 | $171 |
| Travatan Z | 52 | $10,366 | $199 |
| Lotemax | 37 | $8,232 | $222 |
| Combigan | 35 | $5,234 | $150 |
| Diclofenac | 393 | $5,074 | $13 |
| Latanoprost | 353 | $4,617 | $13 |
| Prolensa | 19 | $4,092 | $215 |
| Tobramycin-Dexamethasone | 41 | $3,734 | $91 |
| Ciprofloxacin | 373 | $3,256 | $9 |
| Durezol | 12 | $1,822 | $152 |
| Alphagan P | 12 | $1,808 | $151 |
| Timolol Maleate | 48 | $397 | $8 |
| Erythromycin | 23 | $278 | $12 |
| Ketorolac Tromethamine | 11 | $258 | $23 |
| Neomycin-Polymyxin-Dexameth | 17 | $254 | $15 |
| Brimonidine | 20 | $153 | $8 |
2014: 23 drugs
| Restasis | 114 | $41,986 | $368 |
| Prednisolone Acetate | 407 | $37,832 | $93 |
| Lumigan | 128 | $19,345 | $151 |
| Lotemax | 77 | $14,269 | $185 |
| Travatan Z | 56 | $10,476 | $187 |
| Pataday | 58 | $8,099 | $140 |
| Diclofenac | 457 | $6,917 | $15 |
| Besivance | 52 | $6,142 | $118 |
| Tobramycin-Dexamethasone | 60 | $5,658 | $94 |
| Latanoprost | 266 | $5,056 | $19 |
| Ciprofloxacin | 378 | $4,038 | $11 |
| Prolensa | 13 | $3,473 | $267 |
| Combigan | 25 | $3,069 | $123 |
| Alphagan P | 18 | $2,356 | $131 |
| Durezol | 12 | $1,503 | $125 |
| Azasite | 11 | $1,167 | $106 |
| Brimonidine | 30 | $895 | $30 |
| Timolol Maleate | 49 | $491 | $10 |
| Phenylephrine | 18 | $380 | $21 |
| Tropicamide | 26 | $306 | $12 |
| Erythromycin | 13 | $186 | $14 |
| Ofloxacin | 22 | $177 | $8 |
| Acyclovir | 14 | $105 | $8 |
2013: 32 drugs
| Restasis | 113 | $37,654 | $333 |
| Besivance | 175 | $18,797 | $107 |
| Bromday | 85 | $16,524 | $194 |
| Travatan Z | 90 | $14,521 | $161 |
| Durezol | 123 | $13,633 | $111 |
| Lotemax | 79 | $12,294 | $156 |
| Prednisolone Acetate | 314 | $11,047 | $35 |
| Lumigan | 62 | $9,787 | $158 |
| Pataday | 76 | $9,589 | $126 |
| Diclofenac | 354 | $6,458 | $18 |
| Ciprofloxacin | 327 | $4,534 | $14 |
| Latanoprost | 220 | $4,488 | $20 |
| Nevanac | 26 | $4,331 | $167 |
| Bromfenac | 26 | $3,239 | $125 |
| Prolensa | 17 | $3,006 | $177 |
| Alphagan P | 19 | $2,686 | $141 |
| Vigamox | 25 | $2,626 | $105 |
| Combigan | 25 | $2,594 | $104 |
| Zylet | 15 | $2,525 | $168 |
| Tropicamide | 139 | $1,834 | $13 |
| Brimonidine | 27 | $1,652 | $61 |
| Zioptan | 15 | $1,586 | $106 |
| Azasite | 14 | $1,486 | $106 |
| Tobramycin-Dexamethasone | 12 | $1,481 | $123 |
| Phenylephrine | 53 | $1,065 | $20 |
| Ketorolac Tromethamine | 37 | $786 | $21 |
| Ofloxacin | 101 | $783 | $8 |
| Timolol Maleate | 64 | $701 | $11 |
| Dorzolamide-Timolol | 13 | $622 | $48 |
| Erythromycin | 18 | $283 | $16 |
| Fluorometholone | 13 | $176 | $14 |
| Acyclovir | 13 | $103 | $8 |
Money from drug and device companies
$526 in 2025
| 2025 | 9 | 17 | None | $526 |
| 2024 | 7 | 27 | None | $643 |
| 2023 | 10 | 17 | None | $587 |
| 2022 | 7 | 18 | None | $570 |
| 2021 | 7 | 16 | None | $351 |
| 2020 | 8 | 14 | None | $283 |
| 2019 | 8 | 24 | None | $730 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| RxSight | Rxsight Contact Lens | $109 | 1 payment
|
| Genentech USA | Vabysmo | $100 | 4 payments
|
| Alcon Vision | Tryptyr | $96 | 4 payments
|
| Biotissue Holdings | None | $78 | 2 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $48 | 2 payments
|
| Apellis Pharmaceuticals | Syfovre | $29 | 1 payment
|
See all 17 published payments
| Genentech USA | Meals · 2025-12-10 | Vabysmo | $27 |
| Apellis Pharmaceuticals | Meals · 2025-11-21 | Syfovre | $29 |
| Alcon Vision | Meals · 2025-10-30 | Tryptyr | $28 |
| RxSight | Meals · 2025-10-22 | Rxsight Contact Lens | $109 |
| Biotissue Holdings | Meals · 2025-10-20 | None | $19 |
| Alcon Vision | Meals · 2025-09-23 | Unity | $14 |
| Alcon Vision | Meals · 2025-09-12 | Tryptyr | $38 |
| Genentech USA | Meals · 2025-08-27 | Vabysmo | $29 |
| Tarsus Pharmaceuticals | Meals · 2025-06-13 | Xdemvy | $26 |
| Biotissue Holdings | Meals · 2025-06-11 | None | $60 |
| Abbvie | Meals · 2025-05-21 | Durysta | $18 |
| Genentech USA | Meals · 2025-05-14 | Vabysmo | $23 |
| Alcon Vision | Meals · 2025-05-12 | Clareon | $16 |
| Rayner Intraocular Lenses | Meals · 2025-05-09 | Omidria | $20 |
| Tarsus Pharmaceuticals | Meals · 2025-04-18 | Xdemvy | $23 |
| Dompe US | Meals · 2025-03-20 | Oxervate | $28 |
| Genentech USA | Meals · 2025-01-29 | Vabysmo | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $643
| Abbvie | Durysta | $292 | 15 payments
|
| Genentech USA | Vabysmo | $97 | 4 payments
|
| Astellas Pharma US | Izervay | $86 | 1 payment
|
| Harrow Eye | Iheezo | $75 | 3 payments
|
| Dompe US | Oxervate | $45 | 2 payments
|
| Amgen | Tepezza | $26 | 1 payment
|
| Alcon Vision | Argos | $21 | 1 payment
|
2023: $587
| Alcon Vision | Ngenuity | $158 | 3 payments
|
| Genentech USA | Vabysmo | $89 | 4 payments
|
| Astellas Pharma US | None | $81 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $78 | 1 payment
|
| Beaver-Visitec International | None | $45 | 2 payments
|
| AbbVie | Lumigan | $34 | 2 payments
|
| Rayner Intraocular Lenses | Omidria | $32 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $31 | 1 payment
|
| Regeneron Healthcare Solutions | Eylea | $20 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $18 | 1 payment
|
2022: $570
| Alcon Vision | Argos | $200 | 4 payments
|
| Genentech USA | Vabysmo | $130 | 5 payments
|
| Novartis Pharmaceuticals | Xiidra | $88 | 4 payments
|
| Carl Zeiss Meditec USA | Lumera 700 | $65 | 1 payment
|
| New World Medical | Kahook Dual Blade | $45 | 2 payments
|
| Glaukos | Iaccess | $28 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $14 | 1 payment
|
2021: $351
| Eyevance Pharmaceuticals | Flarex | $87 | 4 payments
|
| Allergan | Lumigan | $69 | 3 payments
|
| Genentech USA | Lucentis | $60 | 3 payments
|
| Omeros | Omidria | $52 | 3 payments
|
| Glaukos | Istent Inject W | $37 | 1 payment
|
| Alcon Vision | Acrysof Iq Panoptix | $27 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $20 | 1 payment
|
2020: $283
| Genentech USA | Lucentis | $59 | 3 payments
|
| Alcon Vision | Centurion | $48 | 2 payments
|
| Novartis Pharmaceuticals | Xiidra | $43 | 2 payments
|
| Allergan | Durysta | $33 | 2 payments
|
| Omeros | Omidria | $32 | 2 payments
|
| Regeneron Healthcare Solutions | Eylea | $25 | 1 payment
|
| Sight Sciences | Tearcare | $24 | 1 payment
|
| Carl Zeiss Meditec AG | None Specified | $19 | 1 payment
|
2019: $730
| Alcon Vision | Luxor | $314 | 6 payments
|
| Novartis Pharmaceuticals | Travatan Z | $187 | 5 payments
|
| Genentech USA | Lucentis | $109 | 5 payments
|
| Omeros | Omidria | $48 | 3 payments
|
| Beaver-Visitec International | None | $29 | 1 payment
|
| Allergan | Lumigan | $17 | 1 payment
|
| Shire North American Group | Xiidra | $17 | 1 payment
|
| Iridex | None | $10 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 81.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1134232648
- Licence
- CA A55787California A55787: Current · expires 2028-02-29
- Trained
- Emory University School of Medicine, 1994 · 32 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A557870
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 255 E Weber Ave, Stockton, CA, 95202
- NPI first listed
- 2006-08-17
- NPI last updated
- 2012-07-17
This is when the NPI record was last certified, not a medical board exam.